Susan Hasty, Publisher
Table of Contents . . . September 29th, 2003Non-Subscriber - Summaries Only
Chronic Liver Disease - Prolonged angiotensin II infusion of normal rats ignites liver injury
Liver Disease - ME3738 protects liver injury models from liver failure
AIDS Therapy - Biopharma inks agreement with Guangdong Medicine Group Corp.
Addiction Medicine - Ethanol-related liver cell death relies on cytokine signals
Chronic Hepatitis B - Specific hepatitis B virus genotypes are a hallmark for chronicity
Chronic Hepatitis C - New therapies look promising for the treatment of hepatitis C virus patients
Chronic Hepatitis C - Several hematologic disorders are linked to hepatitis C virus infection
Hepatitis B Risk Factor - Prevalence of hepatitis B infection high in HIV-infected subjects
Hepatitis C Therapy - Antivirals prevent lymphoproliferative disease in chronic hepatitis C patients
Hepatitis C Virus - Arizona launching program to stop virus from progressing
Stem-Cell Transplantation - N-acetyl-L-cysteine does not affect busulfan pharmacokinetics
Viral Proteomics - Hepatitis C virus core protein regulates cellular mechanisms
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.